Artri King Herbal Supplement Tablets Recalled Nationwide for Undeclared Medication
Amazon is recalling Artri King herbal supplement tablets nationwide due to FDA laboratory findings of undeclared diclofenac, a pharmaceutical medication not listed on the label. The product was marketed without FDA approval.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA Class I classification for this drug recall mandates a minimum severity score of 4. Undeclared pharmaceuticals in products marketed as supplements pose significant health risks through potential drug interactions and unexpected adverse effects.
Plain-English summary
Artri King Reforzado con Ortiga y Omega 3 tablets (500 mg, 100-count bottles) are being recalled due to FDA findings of undeclared diclofenac. The product was marketed without an approved New Drug Application (NDA) or Abbreviated NDA (ANDA).
Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that requires medical oversight. Undeclared medications pose serious health risks through potential drug interactions with other medications, unexpected side effects, and allergic reactions that consumers cannot anticipate.
The recall affects approximately 15,087 bottles distributed nationwide in the United States. The affected lot is LTARTKNGOMG30720, with an expiration date of December 2026. The product was manufactured by PLANTAS MEDICINALES DE MEXICO and distributed through Amazon.com, Inc.
Consumers who have purchased this product should not consume it. For questions, contact Amazon or consult a healthcare provider.
The recalled product
- Product
- Artri King Reforzado con Ortiga y Omega 3 tablets, 500 mg, 100-count bottle, Hecho en Mexico por: PLANTAS MEDICINALES DE MEXICO , Melchor Ocampo No. 55 Local D, Delegacion Xochimilco. C.P. 16800, Mexico, D.F., ASIN B084KSV12L, UPC 7 501031 111190
- Manufacturer
- Amazon.com, Inc.
- Category
- Drug — Herbal Supplement
- Hazard
- undeclared-medication
- drug-interaction-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: LTARTKNGOMG30720
- Exp. Diciembre 2026 (December 2026)
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27